PATRICIA HATTON: Open Payments
NPI 1609451277 · LARGO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$994 in 44 payments from 16 companies in 2025. Trend: 2023 $251 · 2024 $359 · 2025 $994
Food & beverage: $994
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $172 |
| PFIZER INC. | 9 | $168 |
| Novo Nordisk Inc | 6 | $136 |
| Amgen Inc. | 5 | $90 |
| Teva Pharmaceuticals USA, Inc. | 3 | $72 |
| AstraZeneca Pharmaceuticals LP | 4 | $63 |
| Phathom Pharmaceuticals, Inc. | 2 | $45 |
| ABBVIE INC. | 2 | $45 |
| Lilly USA, LLC | 2 | $41 |
| Axsome Therapeutics, Inc. | 1 | $33 |
Products named: XIFAXAN, NURTEC ODT, Wegovy, AUSTEDO XR, OTEZLA, VOQUEZNA, VRAYLAR, MOUNJARO.
Industry payments across FL — which companies pay providers there.
